Key points from article :
Seragon Biosciences completed a pre-clinical study on its novel anti-aging candidate, SRN-901.
The study investigated SRN-901's effects on ageing and various health markers in mice.
SRN-901 significantly extended both lifespan and healthspan in the treated mice.
Gene expression analysis showed increased activity of genes linked to longevity and decreased activity of aging genes.
Treated mice also had a metabolic profile associated with a younger biological age.
Treadmill tests revealed improved endurance in elderly mice given SRN-901.
Frailty scores and tumor occurrence were both significantly reduced.
Further analysis is planned by Seragon Biosciences, and the full results will be published later.
